<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00733096</url>
  </required_header>
  <id_info>
    <org_study_id>08-6891</org_study_id>
    <nct_id>NCT00733096</nct_id>
  </id_info>
  <brief_title>A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Walter Reed Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Naval Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Womack Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Landstuhl Regional Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lumbosacral radiculopathy is one of the leading of cause of disability in the U.S. and
      worldwide. Among recent reviews evaluating epidural steroid injections, some 1 but not all 2
      concluded them to be effective in the long-term. In our own double-blind, placebo-controlled
      study evaluating epidural etanercept, the results showed significant benefit in favor of the
      etanercept group, but no subject was included with a duration of pain &gt; 9 months, and the
      results of this study have yet to be replicated.

      Currently, epidural steroid injections are the most frequently performed procedures in pain
      clinics across the U.S. However, epidural steroids may benefit only a select group of
      patients. The literature on treating sciatica is notable for a lack of randomized comparative
      studies involving various treatments. The objective of this project is to conduct a 3-arm
      study to determine the efficacy of 1) transforaminal epidural corticosteroids; and 2)
      transforaminal epidural etanercept, in patients with lumbosacral radiculopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 3-arm multi-center, randomized, double-blind, placebo-controlled study comparing
      two treatments with transforaminal epidural saline. Each group will receive a 2nd procedure
      identical to the first 2 weeks after the initial procedure.

      Seventy-eight study participants will be randomized via a computerized randomization system
      using SPSS software in groups of 6 at each institution by a research nurse not involved in
      patient care. There will be 26 patients in each of the 3 groups. A physician unaware of the
      patient's treatment group will place 22-gauge needles in the relevant foramen under
      fluoroscopic guidance as determined by patient's symptoms and MRI findings. Once correct
      placement is confirmed by contrast injection, the blinded physician will leave the room and
      another physician will inject the medication. In group I, this will be 60 mg of
      depo-methylprednisolone. In group II, this will be 4 mg of etanercept reconstituted in 2 ml
      of sterile water. In group III, this will be normal saline.

      Two weeks after the initial procedure, an identical procedure to the first one will be done
      by the same physician or his designate. In addition to the study medication, each patient in
      each group will receive 0.5 ml of 0.5% bupivacaine local anesthetic for immediate pain relief
      during both injections before the study drug is delivered. The efficacy of blinding will be
      assessed by a disinterested observer unaware of the randomization results after the second
      procedure before discharge. Follow-up visits will be conducted one, three and six months
      after the second injection, for those subjects who continue to experience &gt; 50% pain relief.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Leg Pain Score</measure>
    <time_frame>1 month</time_frame>
    <description>0-10 pain score. 0= no pain, 10= worst imaginable pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Score</measure>
    <time_frame>1 month</time_frame>
    <description>0-100%. 0= no disability, 100% is complete disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Perceived Effect</measure>
    <time_frame>1 month</time_frame>
    <description>Satisfaction. Number of participants with positive perceived global satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Reduction</measure>
    <time_frame>1 month</time_frame>
    <description>Number of people who reduced medications</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Lumbosacral Radiculopathy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural etanercept 4 mg, two doses 2 weeks apart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epidural methylprednisolone 60 mg, two doses 2 weeks apart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Epidural saline, two doses 2 weeks apart</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etanercept</intervention_name>
    <description>Two transforaminal epidural injections of 4 mg, two weeks apart</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylprednisolone</intervention_name>
    <description>Two transforaminal epidural steroid injections with 60 mg, two weeks apart</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Two transforaminal epidural saline injections, two weeks apart</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Chronic low back pain of radicular origin of &gt; 4 weeks but &lt; 6 months duration.

          2. Leg pain &gt; back pain.

          3. Failure of conservative therapy to include physical and pharmacotherapy.

          4. MRI evidence of a lateral or paracentral herniated disc corresponding to the patient's
             radicular symptoms.

        Exclusion Criteria:

          1. Uncontrolled coagulopathy.

          2. Pregnancy, which will be ruled out by a urine pregnancy test in women of childbearing
             age.

          3. Allergy to contrast dye or amide local anesthetics.

          4. Previous epidural steroid injection within last year.

          5. Unstable medical or psychiatric condition (e.g. unstable angina, congestive heart
             failure or severe depression) that could preclude an optimal treatment response.

          6. Rheumatoid arthritis or spondylarthropathy.

          7. Unstable neurological condition (e.g. multiple sclerosis)

          8. Systemic infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Walter Reed Army Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Womack Army Medical Center</name>
      <address>
        <city>Fort Bragg</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P. Pathophysiology of disk-related sciatica. I.--Evidence supporting a chemical component. Joint Bone Spine. 2006 Mar;73(2):151-8. Epub 2005 Jun 22. Review.</citation>
    <PMID>16046173</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2008</study_first_submitted>
  <study_first_submitted_qc>August 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2008</study_first_posted>
  <results_first_submitted>August 24, 2012</results_first_submitted>
  <results_first_submitted_qc>October 5, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 8, 2012</results_first_posted>
  <last_update_submitted>October 5, 2012</last_update_submitted>
  <last_update_submitted_qc>October 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2012</last_update_posted>
  <responsible_party>
    <name_title>Steven P. cohen</name_title>
    <organization>Walter Reed Army Medical Center</organization>
  </responsible_party>
  <keyword>radiculopathy</keyword>
  <keyword>sciatica</keyword>
  <keyword>low back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Etanercept</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>84 patients were enrolled between 2008 and 2011</recruitment_details>
      <pre_assignment_details>80 patients were excluded before assignment</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Steroid</title>
          <description>Two epidural steroid injections</description>
        </group>
        <group group_id="P2">
          <title>Etanercept</title>
          <description>Two epidural etanercept injections</description>
        </group>
        <group group_id="P3">
          <title>Saline</title>
          <description>Two epidural saline injections</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Steroid</title>
          <description>Two epidural steroid injections</description>
        </group>
        <group group_id="B2">
          <title>Etanercept</title>
          <description>Two epidural etanercept injections</description>
        </group>
        <group group_id="B3">
          <title>Saline</title>
          <description>Two epidural saline injections</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="84"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.4" spread="12.7"/>
                    <measurement group_id="B2" value="43.2" spread="8.9"/>
                    <measurement group_id="B3" value="42.3" spread="10.7"/>
                    <measurement group_id="B4" value="42.29" spread="10.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Numerical Rating Leg Pain Score</title>
        <description>0-10 pain score. 0= no pain, 10= worst imaginable pain.</description>
        <time_frame>1 month</time_frame>
        <population>Patients who received epidural steroid injections</population>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Two epidural steroid injections</description>
          </group>
          <group group_id="O2">
            <title>Etanercept</title>
            <description>Two epidural etanercept injections</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Two epidural saline injections</description>
          </group>
        </group_list>
        <measure>
          <title>Numerical Rating Leg Pain Score</title>
          <description>0-10 pain score. 0= no pain, 10= worst imaginable pain.</description>
          <population>Patients who received epidural steroid injections</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="26"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.54" lower_limit="1.36" upper_limit="3.69"/>
                    <measurement group_id="O2" value="3.56" lower_limit="2.35" upper_limit="4.72"/>
                    <measurement group_id="O3" value="3.78" lower_limit="2.72" upper_limit="4.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oswestry Disability Score</title>
        <description>0-100%. 0= no disability, 100% is complete disability</description>
        <time_frame>1 month</time_frame>
        <population>Patients who received epidural steroid injections</population>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Two epidural steroid injections</description>
          </group>
          <group group_id="O2">
            <title>Etanercept</title>
            <description>Two epidural etanercept injections</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Two epidural saline injections</description>
          </group>
        </group_list>
        <measure>
          <title>Oswestry Disability Score</title>
          <description>0-100%. 0= no disability, 100% is complete disability</description>
          <population>Patients who received epidural steroid injections</population>
          <units>percentage of disability out of 100%</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="26"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.4" lower_limit="16.64" upper_limit="31.55"/>
                    <measurement group_id="O2" value="40.26" lower_limit="32.91" upper_limit="47.61"/>
                    <measurement group_id="O3" value="30.00" lower_limit="23.2" upper_limit="36.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Perceived Effect</title>
        <description>Satisfaction. Number of participants with positive perceived global satisfaction.</description>
        <time_frame>1 month</time_frame>
        <population>Subjects who underwent epidural steroid injections</population>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Two epidural steroid injections</description>
          </group>
          <group group_id="O2">
            <title>Etanercept</title>
            <description>Two epidural etanercept injections</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Two epidural saline injections</description>
          </group>
        </group_list>
        <measure>
          <title>Global Perceived Effect</title>
          <description>Satisfaction. Number of participants with positive perceived global satisfaction.</description>
          <population>Subjects who underwent epidural steroid injections</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="26"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Medication Reduction</title>
        <description>Number of people who reduced medications</description>
        <time_frame>1 month</time_frame>
        <population>Patients who underwent epidural steroid injections</population>
        <group_list>
          <group group_id="O1">
            <title>Steroid</title>
            <description>Two epidural steroid injections</description>
          </group>
          <group group_id="O2">
            <title>Etanercept</title>
            <description>Two epidural etanercept injections</description>
          </group>
          <group group_id="O3">
            <title>Saline</title>
            <description>Two epidural saline injections</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Reduction</title>
          <description>Number of people who reduced medications</description>
          <population>Patients who underwent epidural steroid injections</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="26"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Steroid</title>
          <description>Two epidural steroid injections</description>
        </group>
        <group group_id="E2">
          <title>Etanercept</title>
          <description>Two epidural etanercept injections</description>
        </group>
        <group group_id="E3">
          <title>Saline</title>
          <description>Two epidural saline injections</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Worsening pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nonlocal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Nonlocal rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Subjects who failed to obtain benefit were unblinded after 1-month, which limits conclusions regarding long-term efficacy.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Steven P. Cohen</name_or_title>
      <organization>Johns Hopkins School of Medicine</organization>
      <phone>410-955-1822</phone>
      <email>scohen40@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

